SCHEMBL6068795

SCHEMBL6068795

Cc1cccc(COc2ccc(N)cc2C)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 3/20 0.48
SYK P43405 3/20 0.43
MBOAT4 Q96T53 1/20 0.41
AURKB Q96GD4 1/20 0.41
INCENP Q9NQS7 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
TP53 P04637 2/20 0.40
HSD17B10 Q99714 1/20 0.40
BRD4 O60885 1/20 0.39
BRD2 P25440 1/20 0.39
BRD3 Q15059 1/20 0.39
BRDT Q58F21 1/20 0.39
MPO P05164 1/20 0.39
LMNA P02545 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8308367 0.88 SYK (0.46) MRGPRX4SYKMBOAT4AURKBINCENP
SCHEMBL29963026 0.86 SYK (0.50) MRGPRX4SYKAURKBINCENPNPC1
SCHEMBL1016955 0.86 SYK (0.50) MRGPRX4SYKAURKBINCENPNPC1
SCHEMBL15932884 0.85 NPC1 (0.53) MRGPRX4SYKAURKBINCENPNPC1
SCHEMBL15701529 0.81 MRGPRX4 (0.54) MRGPRX4SYKAURKBINCENPNPC1
SCHEMBL1406446 0.81 SYK (0.65) SYKAURKBINCENPNOS3NOS2
SCHEMBL6104477 0.80 EGFR (0.58) LMNASMN1; SMN2EGFRERBB2
SCHEMBL15932955 0.80 MRGPRX4 (0.46) MRGPRX4SYKAURKBINCENPNPC1
SCHEMBL8285904 0.79 CYP3A4 (0.53) TP53TSHRALDH1A1NOS3NOS2
SCHEMBL30354949 0.78 SYK (0.45) MRGPRX4SYKAURKBINCENPNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7081461-B1 Quinazoline compounds and pharmaceutical compositions containing them ASTRAZENECA AB (SE) 2006-07-25 US disclosed
EP-1218356-A1 QUINAZOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AstraZeneca AB (SE) 2002-07-03 EP disclosed
WO-2001021594-A1 QUINAZOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ASTRAZENECA AB (SE) 2001-03-29 WO disclosed
EP-0790986-B1 ANILINE DERIVATIVES ZENECA LTD (GB) 1999-01-20 EP disclosed
US-5821246-A USEFUL AS TYROSINE KINASE INHIBITORS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER ZENECA LIMITED (GB) 1998-10-13 US disclosed
EP-0790986-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1997-08-27 EP disclosed
WO-1996015118-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1996-05-23 WO disclosed